2024-09-03 - Analysis Report
## CVS Stock Analysis Report

**Company Overview:** CVS Health Corporation is a health care company that operates retail pharmacies, pharmacy benefit management services, and health care services. 

**1. Performance vs. S&P 500 (VOO):**

CVS has underperformed the S&P 500 significantly, with a cumulative return of -17.37% compared to the S&P 500's 89.66%. This puts CVS at a relative divergence of -107.03, meaning it is currently lagging behind the S&P 500 by a considerable margin.

**2. Recent Price Movement:**

* **Closing price:** $57.24
* **5-day Moving Average:** $57.52
* **20-day Moving Average:** $57.56
* **60-day Moving Average:** $58.95

The price is currently trading below the 5-day, 20-day, and 60-day moving averages, suggesting a potential downward trend. 

**3. Technical Indicators:**

* **RSI:** 59.78, indicating the stock is neither overbought nor oversold.
* **PPO:** -0.05, suggesting a weak momentum in the price.
* **Delta_Previous_Relative_Divergence:** -11.1, indicating a recent short-term downward trend.
* **Expected_Return:** 12.6%, representing the potential 5-year return based on current investment.

**4. Recent Earnings & Outlook:**

| Date | EPS | Expected EPS |
|---|---|---|
| 2024-08-07 | 1.83 | 1.73 |
| 2024-05-01 | 1.31 | 1.7 |
| 2024-02-07 | 2.12 | 2.01 |
| 2023-11-01 | 2.21 | 2.13 |
| 2023-08-02 | 2.21 | 2.12 |

The latest earnings report for the quarter ending August 2024 shows that CVS exceeded expectations, reporting an EPS of 1.83 against an estimated 1.73. However, prior quarters show some misses in expectations, highlighting volatility in the company's performance.

**5. Overall Analysis:**

CVS has been underperforming the market significantly, with a substantial lag behind the S&P 500. While the latest earnings report exceeded expectations, previous quarters show some misses, highlighting inconsistencies in the company's performance. Technical indicators also point to a potential downward trend.

**6. Conclusion:**

Despite the recent earnings beat, CVS continues to face significant challenges. The stock's underperformance, negative technical indicators, and inconsistent earnings suggest caution. Investors should closely monitor CVS' future earnings reports and consider its overall market performance before making investment decisions. 
